Axunio

Axunio is a specialty pharmaceutical company based in Hamburg, Germany, dedicated to the development and commercialization of innovative medicinal products for niche markets. The company focuses on creating value-added medicines by optimizing existing active ingredients through new formulations, delivery methods, or fixed-dose combinations. Axunio's primary therapeutic focus areas include pain management, neurology, and oncology, with a portfolio that features both proprietary developments and licensed products. One of their flagship products is Paravex, a fixed-dose combination of paracetamol and ibuprofen designed for enhanced analgesic efficacy. By maintaining a lean organizational structure and a network of strategic partners, Axunio efficiently addresses unmet medical needs in specialized healthcare segments.